重型脑静脉血栓患者去骨瓣减压手术结局:DECOMPRESS2观察性研究
DECOMPRESS2为前瞻性国际队列研究,纳入2011年12月至2019年12月10国15中心118例因重型脑静脉血栓行去骨瓣减压手术的患者,评估12个月死亡或重度残疾(改良Rankin量表5-6分)。结果显示46例(39%)死亡或重度残疾,其中40例(33.9%)死亡,42例(35.6%)独立;昏迷(OR 2.39 [95%CI 1.03-5.56])和固定散大瞳孔(OR 2.22 [95%CI 0.90-4.92])为预测因素;存活者中56例(78.9%)患者和61例(87.1%)照护者认为手术有益。
要点
- 118例重型脑静脉血栓行去骨瓣减压手术患者中,12个月死亡或重度残疾46例(39%),死亡40例(33.9%)。
- 12个月独立(改良Rankin量表0-2分)42例(35.6%)。
- 昏迷(OR 2.39 [95%CI 1.03-5.56])和固定散大瞳孔(OR 2.22 [95%CI 0.90-4.92])为死亡或重度残疾的预测因素。
核心结论
- 重型脑静脉血栓患者去骨瓣减压术后1年,三分之二存活,超过三分之一独立。
- 存活者中约五分之四的患者和照护者认为手术值得。
- 结果支持对即将发生脑疝的脑静脉血栓患者行去骨瓣减压手术的推荐。
研究设计与样本
- DECOMPRESS2为前瞻性国际队列研究,纳入2011年12月至2019年12月10国15中心的连续脑静脉血栓行去骨瓣减压手术患者。
- 共纳入118例患者(80例女性;中位年龄38岁),在入院、出院、6个月和12个月时评估。
- 主要结局为12个月死亡或重度残疾(改良Rankin量表5-6分)。
主要发现
- 手术(115例去骨瓣减压和37例血肿清除)在诊断后中位1天内进行。
- 术前末次评估时,68例(57.6%)昏迷,单侧固定散大瞳孔27例(22.9%),双侧9例(7.6%)。
- 12个月随访数据可获取113例(95.8%);46例(39%)死亡或重度残疾,其中40例(33.9%)死亡;42例(35.6%)独立(改良Rankin量表0-2分)。
- 昏迷(OR 2.39 [95%CI 1.03-5.56])和固定散大瞳孔(OR 2.22 [95%CI 0.90-4.92])为死亡或重度残疾的预测因素。
- 存活者中,56例(78.9%)患者和61例(87.1%)照护者对手术持正面看法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decompressive neurosurgery is recommended for patients with cerebral venous thrombosis (CVT) who have large parenchymal lesions and impending brain herniation. This recommendation is based on limited evidence. We report long-term outcomes of patients with CVT treated by decompressive neurosurgery in an international cohort. METHODS: DECOMPRESS2 (Decompressive Surgery for Patients With Cerebral Venous Thrombosis, Part 2) was a prospective, international cohort study. Consecutive patients with CVT treated by decompressive neurosurgery were evaluated at admission, discharge, 6 months, and 12 months. The primary outcome was death or severe disability (modified Rankin Scale scores, 5-6) at 12 months. The secondary outcomes included patient and caregiver opinions on the benefits of surgery. The association between baseline variables before surgery and the primary outcome was assessed by multivariable logistic regression. RESULTS: A total of 118 patients (80 women; median age, 38 years) were included from 15 centers in 10 countries from December 2011 to December 2019. Surgery (115 craniectomies and 37 hematoma evacuations) was performed within a median of 1 day after diagnosis. At last assessment before surgery, 68 (57.6%) patients were comatose, fixed dilated pupils were found unilaterally in 27 (22.9%) and bilaterally in 9 (7.6%). Twelve-month follow-up data were available for 113 (95.8%) patients. Forty-six (39%) patients were dead or severely disabled (modified Rankin Scale scores, 5-6), of whom 40 (33.9%) patients had died. Forty-two (35.6%) patients were independent (modified Rankin Scale scores, 0-2). Coma (odds ratio, 2.39 [95% CI, 1.03-5.56]) and fixed dilated pupil (odds ratio, 2.22 [95% CI, 0.90-4.92]) were predictors of death or severe disability. Of the survivors, 56 (78.9%) patients and 61 (87.1%) caregivers expressed a positive opinion on surgery. CONCLUSIONS: Two-thirds of patients with severe CVT were alive and more than one-third were independent 1 year after decompressive surgery. Among survivors, surgery was judged as worthwhile by 4 out of 5 patients and caregivers. These results support the recommendation to perform decompressive neurosurgery in patients with CVT with impending brain herniation.
引用
- Aaron S, Ferreira JM, Coutinho JM, et al. Outcomes of Decompressive Surgery for Patients With Severe Cerebral Venous Thrombosis: DECOMPRESS2 Observational Study. Stroke. 2024. PMID: 38572636. doi:10.1161/STROKEAHA.123.045051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。